Huge News For Novo Nordisk Fans

Novo Nordisk NYSE:NVO is considering hair loss as one possible area for future expansion as it looks beyond its core obesity and diabetes franchises, with the idea emerging alongside a broader strategy reset.Chief Scientific Officer Martin Lange said the company could apply its drug-development exp…